# New Mexico Bioscience Authority New Mexico Bioscience Authority is a Sovereign Wealth Fund based in Albuquerque, United States. ## Overview - **Organization type:** Sovereign Wealth Fund - **Headquarters:** Albuquerque, United States - **Region:** North America - **Address:** Albuquerque, NM, United States - **Founded:** 2017 - **Assets under management:** Undisclosed - **Website:** https://www.nmbioscience.org/ - **LinkedIn:** https://www.linkedin.com/company/new-mexico-bioscience-authority ## Regulatory record - **Reports private funds:** No ## About The New Mexico Bioscience Authority was created as a dedicated investment and development vehicle aimed at anchoring a biotechnology and life-sciences ecosystem in a state better known for its federal research facilities than for private risk capital. Its mandate is to deploy state-appropriated funds alongside federal grants and private co-investment into translational research, early-stage medical-device companies, and biotech startups that can build operational footprints in New Mexico. While the precise quantum of state backing is not publicly disaggregated, the Authority's existence reflects a deliberate policy choice by New Mexico to capture more economic value from the massive federal R&D spend concentrated at Sandia National Laboratories and Los Alamos National Laboratory. The Authority's investment strategy spans seed through growth-stage venture capital, with a focus on therapeutics, diagnostics, medical devices, and health IT. Instead of operating as a pure grant-making body, the Bioscience Authority has been structured to make equity investments in spin-outs and to attract out-of-state venture firms to co-invest in local companies. This often means participating in syndicated rounds where the Authority takes a direct stake alongside specialized life-science VCs. Public records and press releases indicate the Authority has backed companies working on technologies licensed from the University of New Mexico's clinical and engineering departments. The geographic focus is overwhelmingly local — Albuquerque, Santa Fe, and the corridor anchored by the national labs. The strategy is intrinsically linked to the state's broader plan to diversify a resource-dependent economy by building a critical mass of science-based companies that can scale without relocating to coastal biotech hubs. In terms of scale, the Authority operates with a lean team embedded within the state's broader economic-development apparatus rather than as a large stand-alone fund. The Authority's work is complemented by other state-linked entities such as the New Mexico Economic Development Department and the technology-transfer offices within the state's universities, forming an interlocking set of public entities rather than a single sovereign wealth fund with a massive balance sheet. The precise number of investment professionals is not publicly itemized, though the structure is consistent with a small, specialized investment office making concentrated bets in a single sector vertical. What separates the Authority from a typical venture firm is its statutory origin and its blended return mandate. It must generate a financial return sufficient to keep the vehicle viable while simultaneously meeting job-creation and company-formation metrics set by state lawmakers. This dual-bottom-line architecture distorts standard venture incentives — the Authority cannot simply follow returns to the coasts; it must engineer them inside a rural, low-density state with a shallow local talent pool. This makes it a unique actor in the venture landscape: a state sovereign vehicle that underwrites technology risk not primarily for IRR, but to slowly build a self-sustaining industry that the private market would otherwise bypass. ## Sectors - Life Sciences - Digital Health - Healthcare Services - Medical Devices ## Questions ### How does the Authority source its deal flow? Deal flow is heavily relationship-driven and institutional, anchored at the state's research universities and federal labs. The University of New Mexico's Health Sciences Center and its technology-transfer office serve as primary feeders, alongside Los Alamos National Laboratory and Sandia National Laboratories. The Authority also relies on introductions from venture-capital firms that are invited to co-invest in New Mexico-based startups, effectively using out-of-state GPs to surface companies that meet the Authority's statutory requirement to invest locally. ### Does the Authority invest in fund-of-funds or only direct co-investments? The Authority primarily engages in direct equity investments and direct co-investments in companies spinning out from New Mexico's labs and universities. It is not known to act as a significant fund-of-funds investor. The model relies on attracting coastal venture firms into local rounds, where the Authority takes a direct equity position alongside them, rather than simply writing checks into independent venture-capital funds. ## Related profiles - [New Haven City Employees Retirement System](https://altss.com/profile/new-haven-conn-city-employees-retirement-system-cerf) - [New Mexico Land Grant Permanent Fund](https://altss.com/profile/new-mexico-land-grant-permanent-fund-lgpf) --- Last updated: 2026-08-11T02:43:31.692Z Canonical page: https://altss.com/profile/new-mexico-bioscience-authority Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology